- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
BioRestorative Therapies Inc (BRTX)
BioRestorative Therapies Inc stock price live, this page displays NASDAQ BRTX stock exchange data. View the BRTX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the BioRestorative Therapies Inc real time stock price chart below.
What Is the BioRestorative Therapies Inc Stock Price Today?
The BioRestorative Therapies Inc stock price today is 1.450.
What Is the Stock Symbol for BioRestorative Therapies Inc?
The stock symbol for BioRestorative Therapies Inc is ""BRTX.""
What Stock Exchange Does BioRestorative Therapies Inc Trade On?
BioRestorative Therapies Inc is listed and trades on the NASDAQ stock exchange.
Is BioRestorative Therapies Inc a Good Stock to Buy?
Determining whether BioRestorative Therapies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BRTX quote. (ISIN: US0906556065)
What Is the BioRestorative Therapies Inc Stock Price Today?
The BioRestorative Therapies Inc stock price today is 1.450.
What Is the Stock Symbol for BioRestorative Therapies Inc?
The stock symbol for BioRestorative Therapies Inc is ""BRTX.""
What Stock Exchange Does BioRestorative Therapies Inc Trade On?
BioRestorative Therapies Inc is listed and trades on the NASDAQ stock exchange.
Is BioRestorative Therapies Inc a Good Stock to Buy?
Determining whether BioRestorative Therapies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BRTX quote. (ISIN: US0906556065)
NASDAQ
Currency in USD
1.450
+0.020(+1.40%)
Closed·
After Hours
1.470+0.020(+1.38%)
·
Fair Value
An estimate of a BioRestorative Therapies's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.380
1.450
52 wk Range
1.210
2.550
BRTX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 3 days
1/2
Fair Value
An estimate of a BioRestorative Therapies's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.3801.450
52 wk Range
1.2102.550
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BRTX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a BioRestorative Therapies's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
13.000
Upside
+796.55%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- Form 8K BioRestorative Therapies Inc For: 13 June
- Investing.com
- Form 8K BioRestorative Therapies Inc For: 13 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
BioRestorative Therapies Inc Company Profile
BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. It develops programs relate to the treatment of disc/spine disease and metabolic disorders. The company’s products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient’s bone marrow, as well as used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure; and ThermoStem, a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. It also operates a commercial biocosmeceutical platform. In addition, the company provides investigational curved needle device to deliver cells and/or other therapeutic products or material to the spine and discs, and other parts of the body. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. is headquartered in Melville, New York.
BioRestorative Therapies Inc Earnings Call Summary for Q1/2025
- Q1 2025 net loss widened to $5.3M ($0.64/share) from $2.2M ($0.33/share) YoY; revenue fell to $25K from $35K
- Stock dropped 2.29% in regular trading and 3.51% after hours, closing at $1.65; company maintains 93% gross profit margins
- Cash position strong at $9.1M with no debt; Phase II trials for BRTX-100 progressing with FDA Fast Track designation
- EPS of -$0.64 missed -$0.26 forecast; company to present 45-patient study data in June, discussions ongoing for ThermoStem license
- Management optimistic on trial progress; analysts' price targets range $8-$18 despite current market challenges
Last Updated: 14/05/2025, 22:22
Read Full TranscriptCompare BRTX to Peers and Sector
Metrics to compare | BRTX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBRTXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.9x | −1.8x | −0.5x | |
PEG Ratio | 0.03 | 0.04 | 0.00 | |
Price/Book | 1.8x | 4.2x | 2.6x | |
Price / LTM Sales | 27.8x | 9.5x | 3.3x | |
Upside (Analyst Target) | - | 319.3% | 43.5% | |
Fair Value Upside | Unlock | 0.5% | 6.8% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 13.000
(+796.55% Upside)
Earnings
Latest Release
May 14, 2025
EPS / Forecast
-0.64 / -0.26
Revenue / Forecast
25.00K / 628.00K
People Also Watch
FAQ
What Stock Exchange Does BioRestorative Therapies Trade On?
BioRestorative Therapies is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for BioRestorative Therapies?
The stock symbol for BioRestorative Therapies is "BRTX."
What Is the BioRestorative Therapies Market Cap?
As of today, BioRestorative Therapies market cap is 10.88M.
What Is BioRestorative Therapies's Earnings Per Share (TTM)?
The BioRestorative Therapies EPS (TTM) is -1.48.
When Is the Next BioRestorative Therapies Earnings Date?
BioRestorative Therapies will release its next earnings report on 11 Aug 2025.
From a Technical Analysis Perspective, Is BRTX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has BioRestorative Therapies Stock Split?
BioRestorative Therapies has split 4 times.
How Many Employees Does BioRestorative Therapies Have?
BioRestorative Therapies has 11 employees.
What is the current trading status of BioRestorative Therapies (BRTX)?
As of 09 Aug 2025, BioRestorative Therapies (BRTX) is trading at a price of 1.45, with a previous close of 1.43. The stock has fluctuated within a day range of 1.38 to 1.45, while its 52-week range spans from 1.21 to 2.55.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.